Compare DERM & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | MFIN |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 233.3M |
| IPO Year | 2021 | 1996 |
| Metric | DERM | MFIN |
|---|---|---|
| Price | $7.79 | $10.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.67 | $12.00 |
| AVG Volume (30 Days) | ★ 192.8K | 41.7K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 4.50% |
| EPS Growth | N/A | ★ 1.06 |
| EPS | N/A | ★ 1.71 |
| Revenue | $59,399,000.00 | ★ $338,783,000.00 |
| Revenue This Year | $18.34 | N/A |
| Revenue Next Year | $54.69 | $5.83 |
| P/E Ratio | ★ N/A | $6.24 |
| Revenue Growth | 2.82 | ★ 15.53 |
| 52 Week Low | $3.54 | $7.71 |
| 52 Week High | $9.40 | $10.98 |
| Indicator | DERM | MFIN |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 62.01 |
| Support Level | $7.52 | $9.96 |
| Resistance Level | $8.53 | $10.39 |
| Average True Range (ATR) | 0.42 | 0.32 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 40.48 | 92.81 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.